Technology

Aposcience AG scientists have made the seminal observation that a complex mixture of cytokines, growth factors and other active components released from peripheral white blood cells have beneficial therapeutic effects. The company now further describes these effects and develops the best available methods to use their therapeutic power.

Furthermore, Aposcience AG investigates the predictive power of certain molecules and their use as biomarkers.

Latest News
Aug
31

Approval of DSMB for Lead In-Phase and Go-Ahead for MARSYAS II Main Study

[more]

May
27

Approval for clinical phase II study in DFU by German health agency PEI

[more]